DiaMedica Therapeutics Inc. (DMAC) vs Kamada Ltd. (KMDA)
A side-by-side comparison of DiaMedica Therapeutics Inc. and Kamada Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMAC
DiaMedica Therapeutics Inc.
$8.50HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
KMDA
Kamada Ltd.
$8.03HealthcareDelayed quote: Oct 6, 2026, 9:59 AM EDT
Total return — DMAC vs KMDA
growth of $100 · dividends reinvested · last 10yDMAC +113.7% (+7.9%/yr)KMDA +65.0% (+5.1%/yr)DMAC compounded faster over this window
DMAC KMDA
DMAC vs KMDA: by the numbers
- •KMDA is the larger company ($463M vs $458M market cap).
- •KMDA is profitable (11.60% net margin) while DMAC runs a net loss (0.00%).
- •KMDA pays a dividend (5.25% yield), while DMAC has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DMAC | KMDA |
|---|---|---|
| P/E ratio | N/A | 21.19 |
| Forward P/E | N/A | 16.82 |
| P/S ratio | N/A | 2.41 |
| P/B ratio | 11.94 | 1.72 |
| EV / EBITDA | N/A | 10.33 |
| FCF yield | N/A | 5.72% |
Profitability
| Metric | DMAC | KMDA |
|---|---|---|
| Gross margin | 0.00% | 40.82% |
| Operating margin | 0.00% | 14.51% |
| Net margin | 0.00% | 11.60% |
| ROE | -97.92% | 8.25% |
| ROIC | -100.87% | 6.95% |
Dividends
| Metric | DMAC | KMDA |
|---|---|---|
| Dividend yield | N/A | 5.25% |
| Payout ratio | N/A | 110.82% |
Growth (annualized)
| Metric | DMAC | KMDA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.59% |
| EPS CAGR (5Y) | N/A | -1.98% |
| FCF CAGR (5Y) | N/A | 40.37% |
| Total return CAGR (5Y) | 16.41% | 10.36% |
Frequently asked
- Does DMAC or KMDA pay a bigger dividend?
- KMDA pays a dividend (5.25% yield), while DMAC has no payments in the available dividend history.
- Is DMAC or KMDA more profitable?
- KMDA runs the higher net margin — DMAC at 0.00% versus KMDA at 11.60%.
- How have DMAC and KMDA total returns compared?
- Over the past 10 years, DMAC delivered 7.89% and KMDA delivered 5.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Kamada P/E ratioKamada dividend yieldDiaMedica Therapeutics ROEKamada ROEDiaMedica Therapeutics operating marginKamada operating marginDiaMedica Therapeutics revenue growthKamada revenue growthDiaMedica Therapeutics free cash flowKamada free cash flow
DiaMedica Therapeutics & Kamada appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.